# Leadinno Medical Valley

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/leadinno-medical-valley

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.leadinno.cn
- Total disclosed funding: $61M
- Latest round: Series B (Aug 17, 2026)
- Investors on record: 16

## About

Based in Beijing, China and established in 2016, Beijing Lingchuang Medical Valley Technology Development Co., Ltd., trading as Leadinno Medical Valley, is a medical technology company that focuses on providing innovative solutions for implantable neuroelectric stimulation treatments for patients with neurological functional diseases. The chief scientist of the company is the founder of the Chinese neuromodulation field, Academician Jisheng Han and the academic leader of Chinese pain medicine, Professor Bifa Fan. In August 2026, it raised over CNY 200 million in Series B+ and Series B++ fundings. 
Leadinno Medical Valley's product line includes an intervertebral surgical system for the minimally invasive treatment of spinal pain and spinal cord electrical stimulation products for the treatment of chronic pain. It also provides innovative solutions for implantable electrical nerve stimulation for patients with functional neurological disorders worldwide.
The company generates revenue from the R&D and sale of pain management and neuromodulation medical device products.
The company will use the Series B+ and Series B++ fundings to advance the registration and commercialization of implantable wireless spinal cord stimulation systems; conduct clinical research and registration translation of implantable wireless peripheral nerve stimulation systems; and increase investment in the research and clinical translation of cutting-edge products such as closed-loop neuromodulation, brain-computer interfaces, and brain-spinal interfaces.

## Funding rounds

- Series B, Aug 17, 2026 — E-town Sun Fund
- Series B, Aug 17, 2026 — China International Capital Corporation, Chuangjing Capital
- Series B, Oct 13, 2025, $28M — Galaxy Capital Management, E-Town International Industrial Investment, Shunxi Fund, Guangzhou Industry Investment Holding Group, Beijing Yizhuang Investment
- Series B, Apr 7, 2025 — E-town international Industrial Investment Management
- Series B, Dec 23, 2024 — Shunxi Fund
- Series A, Oct 25, 2023, $14M — Fortune Capital, Wuxi Zhaoze Lifeng Investment Management
- Series A, Sep 9, 2022, $14M — Cowin Capital, MED-FINE Capital, Proxima Ventures, TigerYeah Capital
- Angel, Apr 7, 2021, $4.4M — Cowin Capital, Chiron Ventures

## Investors

- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Angel, Series A
- Chiron Ventures — Angel
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series A
- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Series A
- TigerYeah Capital (https://capitalatlas.ai/funds/tigeryeah-capital) — Series A
- Fortune Capital — Series A
- Wuxi Zhaoze Lifeng Investment Management — Series A
- Shunxi Fund (https://capitalatlas.ai/funds/shunxi-fund) — Series B
- E-town international Industrial Investment Management — Series B
- Galaxy Capital Management (https://capitalatlas.ai/funds/galaxy-capital-management) — Series B
- E-Town International Industrial Investment (https://capitalatlas.ai/funds/e-town-international-industrial-investment) — Series B
- Guangzhou Industry Investment Holding Group (https://capitalatlas.ai/funds/guangzhou-industry-investment-holding-group) — Series B
- Beijing Yizhuang Investment — Series B
- E-town Sun Fund (https://capitalatlas.ai/funds/e-town-sun-fund) — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B
- Chuangjing Capital (https://capitalatlas.ai/funds/chuangjing-capital) — Series B